- Research article
- Open Access
In vitro α-glucosidase inhibitory activity of phenolic constituents from aerial parts of Polygonum hyrcanicum
© Moradi-Afrapoli et al.; licensee BioMed Central Ltd. 2012
- Received: 4 May 2012
- Accepted: 17 May 2012
- Published: 10 September 2012
Background and the purpose of the study
The early stage of diabetes mellitus type 2 is associated with postprandial hyperglycemia. Hyperglycemia is believed to increase the production of free radicals and reactive oxygen species, leading to oxidative tissue damage. In an effort of identifying herbal drugs which may become useful in the prevention or mitigation of diabetes, biochemical activities of Polygonum hyrcanicum and its constituents were studied.
Hexane, ethylacetate and methanol extracts of P. hyrcanicum were tested for α-glucosidase inhibitory, antioxidant and radical scavenging properties. Active constituents were isolated and identified from the methanolic extract in an activity guided approach.
A methanolic extract from flowering aerial parts of the plant showed notable α-glucosidase inhibitory activity (IC50 = 15 μg/ml). Thirteen phenolic compounds involving a cinnamoylphenethyl amide, two flavans, and ten flavonols and flavonol 3-O-glycosides were subsequently isolated from the extract. All constituents showed inhibitory activities while compounds 3, 8 and 11 (IC50 = 0.3, 1.0, and 0.6 μM, respectively) were the most potent ones. The methanol extract also showed antioxidant activities in DPPH (IC50 = 76 μg/ml) and FRAP assays (1.4 mmol ferrous ion equivalent/g extract). A total phenol content of 130 mg/g of the extract was determined by Folin-Ciocalteu reagent.
This study shows that P. hyrcanicum contains phenolic compounds with in vitro activity that can be useful in the context of preventing or mitigating cellular damages linked to diabetic conditions.
- Polygonum hyrcanicum
- Cinnamoylphenethyl amide
The early stage of diabetes mellitus type 2 is associated with postprandial hyperglycemia due to impaired after-meal acute insulin secretion. Hyperglycemia is believed to increase the production of free radicals and reactive oxygen species, leading to oxidative tissue damage and diabetic complications such as nephropathy, neuropathy, retinopathy, and memory impairment. Glucosidases are a group of digestive enzymes which break down the dietary carbohydrates into simple monosaccharides. Glucosidase inhibitors such as acarbose reduce the rate of carbohydrate digestion and delay the carbohydrate absorption from the digestive tract. Therefore, they have a potential to prevent the development of type 2 diabetes mellitus by lowering the after-meal glucose levels.
Polygonum species are valuable medicinal plants which possess interesting biological activities such as anti-inflammation, cardiovascular protection, neuroprotection, and mitigation of biochemical processes involved in age-related neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. It is believed that these beneficial effects are, at least in part, due to antioxidant and radical scavenging properties of the plant. Moreover, some Polygonum species were reported to possess glucosidase inhibitory properties. Phenylpropanoid glycosides of P. sachalinense and tannins of P. cuspidatum were subsequently identified as active compounds.
Polygonum hyrcanicum is an endemic species that grows widely in northern areas of Iran. In folk medicine of the Turkmen Sahra region (southeast of the Caspian Sea), decoctions made from aerial parts of the plant are used for the treatment of liver problems, anemia, hemorrhoids, and kidney stones. To our knowledge, no biological or phytochemical investigation has been carried out with this species. To explore the plant’s properties with respect to potential prevention or mitigation of cellular damages linked to diabetic conditions, different extracts of P. hyrcanicum were tested for α-glucosidase inhibitory, antioxidant and radical scavenging properties. Active constituents were isolated and identified from the methanolic extract.
Column chromatography was carried out using silica gel (230–400 mesh) obtained from Merck (Germany), RP-18 (230–400 mesh) and Sephadex LH-20 procured from Fluka (Switzerland). Pre-coated silica gel 60 F254 plates and silica gel 60 RP-18 F254S plates (Merck, Germany) were used for TLC. Spots were observed under UV at 254 and 366 nm and spraying with anisaldehyde-H2SO4 reagent (Sigma-Aldrich Chemie, Germany) and heating at 120°C for 5 min. HPLC separations were performed on a Knauer Wellchrom system connected to a photodiode array detector (Smart line system, Germany). 1H and 13C NMR spectra were measured on a Bruker Avance DRX 500 spectrometer operating at 500 MHz for 1H and 125 MHz for 13C using a 5 mm PABBO probehead. α-glucosidase (EC 18.104.22.168, from baker’s yeast, 77 U/mg), p-nitrophenyl-α-d-glucopyranoside, vitamin E 97% and 2, 2-diphenyl-picrylhydrazyl (DPPH) were obtained from Sigma-Aldrich Chemie (Germany). Sodium carbonate, FeCl3, sodium acetate, ferrous sulfate [FeSO4.7H2O], gallic acid, 2, 4, 6-tripyridyl-s-triazine (TPTZ) solution, and Folin-Ciocalteu reagent were all obtained from Merck (Germany).
Aerial parts of Polygonum hyrcanicum Rech. f. at full flowering stage were collected in September 2008 near the village of Veresk (Mazandaran Province) in the north of Iran. The plant material was identified by the forth co-author. A voucher specimen (6729-TEH) has been deposited at the Herbarium of the Faculty of Pharmacy, Tehran University of Medical Sciences.
Extraction and isolation
Shade-dried aerial parts of the plant (1200 g) were cut to small pieces and macerated with n-hexane, ethyl acetate, and methanol, successively, at room temperature (3 × 48 hours with each solvent). The extracts were concentrated under reduced pressure, then freeze dried, resulting in dry extracts of hexane (14 g), ethyl acetate (12 g), and methanol (150 g).
Methanol extract (150 g) of P. hyrcanicum was suspended in ethyl acetate and divided into an ethyl acetate–soluble portion (ESP, 15 g) and methanol–soluble portion (MSP, 135 g). The ESP was applied to normal phase silica gel column chromatography (5 × 45 cm) and eluted with CHCl3, CHCl3:EtOAc (6:4, 2:8), EtOAc, and MeOH, successively. Seven fractions (ESP1-7) were collected. ESP3 (375 mg) and ESP5 (190 mg) were purified on a Sephadex LH-20 column eluted with MeOH:EtOAc (2:1), to afford compounds 1 (12 mg) and 2 (4 mg), respectively. ESP6 (450 mg) was separated on a Sephadex LH-20 column eluted with MeOH:EtOAc (4:1) to give subfractions ESP6-1–ESP6-6. ESP6-2 (42 mg) was subjected to RP chromatography on an RP-18 column eluted with a step gradient of aqueous MeOH (MeOH 40% to 100%). Compounds 3 (11 mg) and 4 (2 mg) were obtained. Compounds 5 (3.5 mg) and 6 (5.5 mg) were purified from ESP6-3 (52 mg) by an RP-18 column eluted with aqueous MeOH (50% to 100%). ESP6-4 (19 mg) and ESP6-5 (28 mg) were separately chromatographed on an RP-18 column eluted with water:MeOH (1:1) to give compounds 7 (5 mg) and 8 (5 mg), respectively.
A portion of the MSP (20 g) was applied to an RP-18 silica gel column eluted with a step gradient of water:MeOH (8:2, 7:3, 5:5, 3:7, 0:10), yielding seven sub-fractions (MSP1–MSP7). Compound 9 (5.6 mg) was obtained by semi-preparative HPLC of MSP3 (128 mg) on an RP-18 column (250 × 20 mm, 7 μm). Water (solvent A) and MeOH (solvent B) were used as mobile phase (0–20 min, 40% B; 20–21 min, 40–50% B; 21-31 min, 50% B; 31–45 min, 50–60% B; 45–46 min, 60–100% B; 46-51 min, 100% B; flow rate of 4 ml/min). Subfraction MSP4 (596 mg) was separated on a Sephadex LH-20 column (MeOH) into four fractions (MSP4-1–MSP4-4). Semi-preparative RP-18 HPLC of MSP4-2 with water (solvent A) and MeOH (solvent B) as the mobile phase (0–30 min, isocratic elution with 50% B; 30–35 min, 100% B, lasting for 5 minutes; flow rate: 4 ml/min) yielded pure 10 (5.4 mg) and 11 (11 mg). MSP4-4 was separated on a Sephadex LH-20 column (MeOH) to give compound 12 (7.5 mg). Compound 13 (17 mg) was purified from MSP5 (1.148 g) by chromatography on a Sephadex LH-20 column eluted with MeOH–water (8:2) followed by RP-18 chromatography (aqueous MeOH 20–100%). The purified compounds were identified using spectroscopic methods (1H and 13C NMR, 2D NMR involving COSY, HSQC, and HMBC) and comparison with literature data. The NMR spectra of compound 4 were previously recorded only in acetone-d6 and no 13C-NMR data have been reported for compound 5 up to now.
Compound 4: 1 H NMR (DMSO-d6, 500 MHz); δ = 7.45 (brs, H-2'), 7.43 (d, J = 8.1 Hz, H-6'), 6.92 (d, J = 8.1 Hz, H-5'), 6.45 (brs, H-8), 6.25 (brs, H-6), 5.66 (brs, H-1"), 4.74 (br d, J = 4.1 Hz, H-3"), 4.38 (brs, H-2"), 4.17 (dd, J = 11.7, 3.5 Hz, H-5"), 3.96 (dd, J = 11.7, 6.4 Hz, H-5"), 3.81 (m, H-4"), 2.13 (s, CH3), 1.98 (s, CH3); 13 C NMR (DMSO- d6, 125 MHz); δ = 178.0 (C-4), 170.2, 170.5 (COO), 164.5 (C-7), 161.7 (C-5), 157.6 (C-2), 156.7 (C-9), 149.0 (C-4'), 145.5 (C-3'), 133.7 (C-3), 121.5 (C-6'), 121.0 (C-1'), 116.1 (C-2'), 115.6 (C-5'), 108.4 (C-1"), 103.9 (C-10), 99.2 (C-6), 94.0 (C-8), 82.4 (C-4"), 79.4 (C-2"), 79.7 (C-3"), 63.5 (C-5"), 20.7, 20.5 (CH3)
Compound 5: 1 H NMR (MeOD, 500 MHz); δ = 7.47 (brs, H-2'), 7.44 (d, J = 8.2 Hz, H-6'), 6.88 (d, J = 8.2 Hz, H-5'), 6.37 (brs, H-8), 6.19 (brs, H-6), 5.72 (br s, H-1"), 4.81(d, J = 3.8, H-3"), 4.44 (brs, H-2"), 3.70 (d, J = 3.8, H-4"), 3.53 (2 H, H-5"), 2.80 (s, CH3); 13 C NMR (MeOD, 125 MHz); δ = 179.4 (C-4), 172.4 (COO), 166.3 (C-7), 163.1 (C-5), 159.6 (C-2), 158.5 (C-9), 149.6 (C-4'), 146.3 (C-3'), 135.0 (C-3), 123.2 (C-1'), 123.0 (C-6'), 117.3 (C-5'), 116.0 (C-2'), 109.8 (C-1"), 105.7 (C-10), 99.9 (C-6), 94.8 (C-8), 86.8 (C-4"), 81.3 (C-3"), 81.2 (C-2"), 62.5 (C-5"), 20.9 (CH3).
Sugar moieties of glycoside structures were detected by GC-MS analysis after acid hydrolysis and derivatization with L-cysteine methyl ester and silylation.
α-Glucosidase inhibition assay
The IC50 values of samples were calculated and reported as the mean ± standard deviation (SD) of three experiments.
DPPH free radical scavenging activity
The antioxidant activities of the extracts were determined with the DPPH assay according to an established protocol. Extract solutions of 500, 250, 100, and 50 μg/ml were prepared in methanol. Each test tube contained 1 ml of the samples and 2 ml freshly prepared DPPH solution of 40 μg/ml in methanol. Negative control tubes were the same as the test tubes, except that they did not include DPPH. Absorbance of the mixtures were recorded at 517 nm after 30 minutes, against the blank covets of DPPH solution. Vitamin E was used as a positive control. All samples were assayed in triplicate and IC50 values were calculated.
Antioxidant activities of plant extracts were evaluated by monitoring their ferric-reducing abilities. Freshly prepared FRAP reagent contained 5 ml FeCl3 (20 mM) plus 5 ml of a 10 mM TPTZ solution in 40 mM HCl and 50 ml of 300 mM acetate buffer (pH = 3.6). One hundred microliters of the samples, dissolved in methanol at various concentrations, were mixed with 3 ml FRAP reagent and incubated at 37°C for 10 minutes; the absorptions at 593 nm were recorded. A calibration curve was generated in the range of 125–750 μM ferrous sulfate (FeSO4.7H2O). Vitamin E was used as a positive control and the results were expressed as mmol ferrous ion equivalent per gram of extracts.
Determination of total phenolic content
Total phenolic contents of extracts were assessed using Folin-Ciocalteu reagent. The reagent was diluted 10-fold with distilled water. Two hundred microliters of appropriate dilutions of extracts were added to 1.5 ml reagent and allowed to stand at room temperature for 5 minutes. Sodium bicarbonate solution (1.5 mL, 60 g/L) was added to the mixture and stored at room temperature for an additional 90 minutes; absorptions at 725 nm were recorded. Known concentrations of gallic acid (0–100 μg/ml in methanol) were applied as standard samples and a calibration curve was created. Total phenolic contents were expressed as mg of gallic acid equivalents (GAE) per gram of dry extracts.
In vitro activities and total phenol content of P. hyrcanicum extracts
α-Glucosidase inhibition IC50(μg/ml)
DPPH assay IC50(μg/ml)
FRAP assay (mmol ferrous ion equivalent/g)
Total phenol content (mg gallic acid equivalent/g)
56.20 ± 1.2
42.30 ± 0.9
146.6 ± 5.2
0.54 ± 0.21
20.30 ± 2.5
15.30 ± 0.5
76.00 ± 3.4
1.37 ± 0.42
135.00 ± 4.4
14.12 ± 0.9
2.40 ± 0.76
8.70 ± 1.1
The sugar moiety of compounds 9 and 11 were confirmed to be D-galactose (RT = 31.1 min) and compound 10 was verified to have an L-rhamnose (RT = 26.7 min). All the compounds were isolated from P. hyrcanicum for the first time. Compounds 4, 5, and 6 are rare flavonoids with mono- or diacetylglycosyl moieties which have not been detected in the Polygonum genus up to now.
α-Glucosidase inhibitory activity (IC 50 ) of phenolic compounds 1-13
3.3 ± 2.0
1.3 ± 0.6
0.3 ± 0.3
4.9 ± 1.5
4.8 ± 1.9
5.8 ± 2.8
6.6 ± 3.5
1.0 ± 0.3
4.8 ± 0.8
0.6 ± 0.2
6.7 ± 3.0
4.2 ± 2.9
7.6 ± 0.9
13.5 ± 1.7
Since oxidative stress is considered as a key factor in the pathogenesis of diabetic complications, antioxidant properties of the extracts were also studied. DPPH radical scavenging activity and ferric reducing power of P. hyrcanicum extracts are summarized in Table 1. The methanolic extract showed noticeable antioxidant activities in both DPPH (IC50 = 76.0 μg/ml) and FRAP (1.4 mmol ferrous ion equivalent/g) assays compared to vitamin E (IC50 = 14.1 μg/ml, FRAP value of 2.4 mmol ferrous ion equivalent/g) as the positive control. The ethyl acetate extract was a moderate antioxidant, while the hexane extract was not active at the concentrations tested. The antioxidant properties were in accord with the total phenol content of the extracts (Table 1). Methanol and ethyl acetate extracts contained 135.0 mg and 20.3 mg gallic acid equivalent/g, respectively, and the hexane extract was free of phenolic constituents.
In the perspective of identifying traditional herbal drugs which might be useful in preventing or mitigating cellular damages related to diabetes, we carried out the first study of the Persian edible plant, P. hyrcanicum. The methanolic extract, in particular, showed promising α-glucosidase, antioxidant, and radical scavenging activities and thirteen phenolic compounds were purified in an activity-guided approach. All the isolated compounds (IC50 = 0.3–7.6 μM) were more potent than the positive control acarbose (IC50 = 13.5 μM). This study suggests that P. hyrcanicum is a promising source of active compounds that can prevent the development of diabetes mellitus type 2 and its complications. While these in vitro results are of a preliminary nature, further investigation of P. hyrcanicum, in particular, in vivo pharmacological testing of the methanolic extract is warranted. These studies will provide a more in depth picture on the potential of this interesting traditional Persian plant.
The research is supported by a Tehran University of Medical Sciences and Health Services grant (No. 56-8516). Special thanks go to Orlando Fertig and Samad N. Ebrahimi for sugar analysis at the University of Basel.
- Maritim AC, Sanders RA, Watkins JB: Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxic. 2003, 17: 24-38. 10.1002/jbt.10058.View ArticleGoogle Scholar
- Liu L, Deseo MA, Morris C, Winter KM, Leach DN: Investigation of α-glucosidase inhibitory activity of wheat bran and germ. Food Chem. 2011, 126: 553-561. 10.1016/j.foodchem.2010.11.041.View ArticleGoogle Scholar
- Bralley EE, Greenspan P, Hargrove JL, Wicker L, Hartle DK: Topical anti-inflammatory activity of Polygonum cuspidatum extract in the TPA model of mouse ear inflammation. J Inflamm. 2008, 5: 1-7. 10.1186/1476-9255-5-1.View ArticleGoogle Scholar
- Yim TK, Wu WK, Pak WF, Mak DHF, Liang SM, Ko KM: Myocardial protection against ischaemia-reperfusion injury by a Polygonum multiflorum extract supplemented ‘Dang-Gui decoction for enriching blood’, a compound formulation, ex vivo. Phytother Res. 2000, 14: 195-199. 10.1002/(SICI)1099-1573(200005)14:3<195::AID-PTR629>3.0.CO;2-4.View ArticlePubMedGoogle Scholar
- Wang T, Gu J, Wu PF, Wang F, Xiong Z, Yang YJ: Protection by tetrahydroxystilbene glucoside against cerebral ischemia: involvement of JNK, SIRT1, and NF-κB pathways and inhibition of intracellular ROS/RNS generation. Free Radical Bio Med. 2009, 47: 229-240. 10.1016/j.freeradbiomed.2009.02.027.View ArticleGoogle Scholar
- Um MY, Choi WH, Aan JY, Kim SR, Ha TY: Protective effect of Polygonum multiflorum Thunb on amyloid β-peptide 25-35 induced cognitive deficits in mice. J Ethnopharmacol. 2006, 104: 144-148. 10.1016/j.jep.2005.08.054.View ArticlePubMedGoogle Scholar
- Li X, Matsumoto K, Murakami Y, Tezuka Y, Wu Y, Kadota S: Neuroprotective effects of Polygonum multiflorum on nigrostriatal dopaminergic degeneration induced by paraquat and maneb in mice. Pharmacol Biochem Behav. 2005, 82: 345-352. 10.1016/j.pbb.2005.09.004.View ArticlePubMedGoogle Scholar
- Fan P, Terrier L, Hay AE, Marston A, Hostettmann K: Antioxidant and enzyme inhibition activities and chemical profiles of Polygonum sachalinensis F.Schmidt ex Maxim (Polygonaceae). Fitoterapia. 2010, 81: 124-131. 10.1016/j.fitote.2009.08.019.View ArticlePubMedGoogle Scholar
- Tang W, Shen Z, Yin J: Inhibitory activity to glycosidase of tannins from Polygonum cuspidatum. Tianran Chanwu Yanjiu Yu Kaifa. 2006, 18: 266-268.Google Scholar
- Mozaffarian V: A dictionary of Iranian plant names. 2007, Tehran: Farhang MoaserGoogle Scholar
- Ghorbani A: Studies on pharmaceutical ethnobotany in the region of Turkmen Sahra, north of Iran: (Part 1): General results. J Ethnopharmacol. 2005, 102: 58-68. 10.1016/j.jep.2005.05.035.View ArticlePubMedGoogle Scholar
- Chai XY, Xu ZR, Ren HY, Shi HM, Lu YN, Li FF: Itosides A-I, new phenolic glycosides from Itoa orientalis. Helv Chim Acta. 2007, 90: 2176-2185. 10.1002/hlca.200790225.View ArticleGoogle Scholar
- McCue P, Kwon YI, Shetty K: Anti-amylase, anti-glucosidase and anti angiotensin I converting enzyme potential of selected foods. J Food Biochem. 2005, 29: 278-294. 10.1111/j.1745-4514.2005.00020.x.View ArticleGoogle Scholar
- Yassa N, Razavi Beni H, Hadjiakhoondi A: Free radical scavenging and lipid peroxidation activity of the Shahani black grape. Pak J Biol Sci. 2008, 11: 1-4.View ArticleGoogle Scholar
- Benzie IF, Strain JJ: The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem. 1996, 239: 70-76. 10.1006/abio.1996.0292.View ArticlePubMedGoogle Scholar
- Al-Farsi M, Alasalvar C, Morris A, Baron M, Shahidi F: Comparison of antioxidant activity, anthocyanins, carotenoids, and phenolics of three native fresh and sun-dried date (Phoenix dactylifera L.) varieties grown in Oman. J Agr Food Chem. 2005, 53: 7592-7599. 10.1021/jf050579q.View ArticleGoogle Scholar
- Shen CC, Chang YS, Hott LK: Nuclear magnetic resonance studies of 5,7-dihydroxyflavonoids. Phytochem. 1993, 34: 843-845. 10.1016/0031-9422(93)85370-7.View ArticleGoogle Scholar
- Santos LP, Boaventura MA, de Oliveira AB, Cassady JM: Grossamide and N-trans-caffeoyltyramine from Annona crassiflora seeds. Planta Med. 1996, 62: 76-10.1055/s-2006-957809.View ArticlePubMedGoogle Scholar
- Chin YW, Kim J: Three new flavonol glycosides from the aerial parts of Rodgersia podophylla. Cheml Pharml Bull. 2006, 54: 234-236. 10.1248/cpb.54.234.View ArticleGoogle Scholar
- Takemoto T, Miyase T: Studies on constituents of Boehmeria tricuspis Makino. I. Yakugaku Zasshi. 1974, 94: 1597-1602.PubMedGoogle Scholar
- Torres-Mendoza D, González J, Ortega-Barría E, Heller MV, Capson TL, McPhail K: Weakly antimalarial flavonol arabinofuranosides from Calycolpus warszewiczianus. J Nat Prod. 2006, 69: 826-828. 10.1021/np050484i.View ArticlePubMedGoogle Scholar
- Lee SS, Wang JS, Chen KCS: Chemical constituents from the roots of Zyziphus jujube Mill. Var. spinosa (I). J Chinese Chem Soc. 1995, 42: 77-82.View ArticleGoogle Scholar
- Zhang Y, Zhang Q, Wang B, Li L, Zhao Y: Chemical constituents from Ampelopsis grosseden ta ta. JCPS. 2006, 15: 2-Google Scholar
- Lin HY, Kuo YH, Lin YL, Chiang W: Antioxidative Effect and Active Components from Leaves of Lotus (Nelumbo nucifera). J Agr Food Chem. 2009, 57: 6623-6629. 10.1021/jf900950z.View ArticleGoogle Scholar
- Gohar A, Gedara SR, Baraka HN: New acylated flavonol glycoside from Ceratonia siliqua L. seeds. J Med Plants Res. 2009, 3: 424-428.Google Scholar
- Young-Won C, Song Won, Young Choong K, Sang Zin C, Kang Ro L, Jinwoong K: Hepatoprotective flavonolglycosides from aerial parts of Rodgersia podophylla. Planta Med. 2004, 70 (6): 576-577. 10.1055/s-2004-827163.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.